lunes, 1 de febrero de 2010

AstraZeneca empieza el año "cortando" y GSK "acolita"...

The new cuts follow the loss of 12,600 roles at the group since 2007. The company, the UK's second biggest drug maker, said the jobs cuts would be made over the next five years, and would affect its operations across the world.

Mas...




Y GlaxoSmithKline que la "acolita"...

"GlaxoSmithKline
will this week announce reduced investment some disease areas and more than 3,000 job cuts as it intensifies its diversification away from its core pharmaceutical business."

(Ver...)


No hay comentarios: